Skip to Content

Neoadjuvant chemotherapy for primary operable breast cancer: A quality assessment of the NACT-regime

This study aimed to investigate the efficacy of the 2016 guidelines for primary operable breast cancer, initiating with six cycles of neoadjuvant chemotherapy prior to surgery. Findings indicate that this regime is a favourable treatment strategy, as a majority underwent lumpectomies and were spared of axillary dissection

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top